Liver and metabolic nutrition
10Choline, methionine and inositol component evidence.
Weight managementBlend
Lipo-C
Variable methionine–inositol–choline nutrient blend
Community reportsWeight management · energy1
Investigational or nonstandard product; no FDA-approved formulation verified for this exact entry.
What does it do?
Variable MIC/B-vitamin injection blend. Nutrient deficiency treatment and biochemical roles do not establish weight-loss efficacy for the mixture.
Approved & studied uses
No established medical use is documented for this formulation.
Community uses Reported, unvalidated
Fat/weight management
10Limited direct blend evidence; carnitine findings apply only if included.
Energy/deficiency
10B12 benefit strongest when deficient or malabsorbing; excess does not prove more energy.
Reasons people report using it; these do not establish benefit.10
Evidence limits
View research →No validated combined-product PK, interactions or clinical response timeline.1
0 distinct primary sources or abstracts checked. Evidence may concern a parent compound, individual blend ingredient, animal, or cell model; it does not necessarily establish a benefit for this exact product.
Evidence definitions →Key safety information
All risks →Human safety is unresolved
The checked material does not establish a human adverse-event rate or safe self-use regimen for this exact product.1
Investigational or nonstandard product; no FDA-approved formulation verified for this exact entry.
Molecular information
Amino-acid sequence
This blend contains multiple compounds and has no single amino-acid sequence.
Multiple componentsComposition varies
LengthNot a single peptide
Molecular weight · DaNo single molecular weight
Formula, sequence notation & identity
Molecular formulaNo single formula1
Variable methionine–inositol–choline nutrient blend
Ingredient identities and quantities vary by formulation.
Pharmacokinetics
How long does it stay in the body?
Reported half-lifeNo verified human estimate1
No numerical curve is shown without an exact compound, formulation and human-route match.
What to expect
Study outcomes
Ingredient evidence does not test the blend
The listed bibliography concerns individual nutrients, other formulations or broad nutrition research. No controlled study of this exact named injectable combination was identified in the targeted search.1
Community poll 10 topics · Pep-Pedia snapshot
Voluntary, unverified reports. These percentages do not measure effectiveness or safety.
Experience
Number of responses to this question: not disclosed.
Duration of use
The source hides 2 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Age range
The source hides 1 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Gender
Number of responses to this question: not disclosed.
Primary goal
The source hides 5 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Effectiveness
The source hides 2 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Side effects
The source hides 2 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Dosage frequency
The source hides 1 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Would recommend
Number of responses to this question: not disclosed.
How discovered
The source hides 2 additional categories. Their labels and percentages are unavailable.
Number of responses to this question: not disclosed.
Source & limitations
The source displays “712 responses” for this profile. This is not a confirmed participant count or a denominator for individual questions.
- Voluntary self-reports from Pep-Pedia visitors; identity, treatment, outcomes and timing are unverified. These data are not efficacy or safety estimates.
- The source displays a profile-wide response label, not a confirmed unique participant count. It stays unchanged across questions. Question-specific denominators and absolute option counts are not exposed.
- Only the top five categories are displayed for some questions. Extra categories are retained as an undisplayed-category count; their labels and percentages are unavailable.
- Displayed percentages are rounded. They may not total 100%, especially where categories are hidden.
- This is a dated snapshot, not a live survey or current recommendation.
Protocols
Doses & schedules
Compare purpose, amount, route, frequency, and duration.
Source corrections
No standardized formulation or validated universal cycle; source compatibility labels are not safety findings.
Route
Scroll to compare all columns →
| Route | Dose | Frequency | Goal / evidence | Duration | References |
|---|---|---|---|---|---|
| SubQSubcutaneous | 1 mL | 1x weekly | General wellness supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source route wording IM or SubQ Source tabs Injectable | |||||
| IMIntramuscular | 1 mL | 1x weekly | General wellness supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source route wording IM or SubQ Source tabs Injectable | |||||
| SubQSubcutaneous | 1-2 mL | 1-2x weekly | Weight management programReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source route wording IM (clinic) or SubQ (home) Source tabs Injectable | |||||
| IMIntramuscular | 1-2 mL | 1-2x weekly | Weight management programReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source route wording IM (clinic) or SubQ (home) Source tabs Injectable | |||||
| SubQSubcutaneous | 1 mL | 1x weekly | Liver health supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source route wording IM or SubQ Source tabs Injectable | |||||
| IMIntramuscular | 1 mL | 1x weekly | Liver health supportReference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source route wording IM or SubQ Source tabs Injectable | |||||
| IMIM preferred for B12 | 1 mL | Weekly initially, then monthly | Energy support (B12 deficiency)Reference report | 4-12 weeks typical program length | 10 |
Population Population not independently verified; see the reference and linked research. Context Reported in Pep-Pedia’s educational protocol table. Study attribution and applicability to this exact product are not independently established. No standardized formulation or validated universal cycle; source compatibility labels are not safety findings. Source tabs Injectable | |||||
No protocols match these filters.
Study and label doses retain their study context. Reference reports are unvalidated practices, not personal treatment instructions. Ranges remain ranges; escalation stages are labeled.
Reported use periods and breaks. These do not establish a safe cycle or prove that breaks prevent tolerance.
Injectable
- Use period
- 4-12 weeks typical program length
- Break
- Breaks not typically required - can be used ongoing as nutritional support
Reported timing
Morning preferred for energy benefits. Can be taken any time.
Side effects & safety
Human safety is unresolved
The checked material does not establish a human adverse-event rate or safe self-use regimen for this exact product.
1Formulation uncertainty
Verify ingredients; added weight-loss drugs have separate risks. Compounded mixtures lack FDA efficacy approval.
Ingredient effects
Choline excess causes odor, sweating/GI symptoms; liver disease warrants methionine review.
Stop symptoms
Allergy, injection infection/fever, severe GI symptoms, weakness or deterioration.
Not a complete safety screen. Discuss health decisions with a qualified clinician.
Combinations & interactions
7 entriesCheck cautions and reported pairings. A compatibility claim does not establish that a combination is safe.
B12 supplements
Caution reportedDuplicate nutrient exposure.10
Reference report · Pep-Pedia label: Monitor CombinationDiabetes medications
Caution reportedAdded drugs/formulation determine glucose risk.10
Reference report · Pep-Pedia label: Monitor CombinationMAOIs
Caution reportedSource flags psychiatric-medication concerns.10
Reference report · Pep-Pedia label: Use CautionSemaglutide
Unverified pairingClinic practice, not proven blend benefit.10
Reference report · Pep-Pedia label: CompatibleTirzepatide
Unverified pairingCombination safety unestablished.10
Reference report · Pep-Pedia label: CompatibleMetformin
Unverified pairingProposed metabolic complement.10
Reference report · Pep-Pedia label: CompatibleOther medicines and research compounds
Not establishedNo clinical interaction study for the exact proposed combination was verified; absence of evidence does not establish compatibility.1
Research contextNo matching interactions. Try another name or filter.
Reconstitution
A blend name does not specify concentration, ingredients or a diluent. Use the exact product documentation; no universal dilution is established.1
Reference preparation details
Reported handling information, not a validated formulation or instruction to prepare an injectable product.
Injectable
The source describes a premixed injectable blend requiring no reconstitution.
- Form
- Source describes a prepared product
Concentration and storage depend on the actual compounded product.
Appearance & documentation
Appearance and a purity certificate cannot establish sterility, identity, or suitability for injection.
Reported appearanceLicensed Compounding PharmacyReported appearanceClear LabelingReported appearanceHealthcare Provider PrescriptionReported variationFormulation VariationsReported variationAdded MedicationsReported concernUnregulated Sources
10Available forms
No verified packaging examples included.
Amounts are total blend mass. Formulas and ratios vary. Approved and research products are not interchangeable.
Storage after mixing
Reconstituted research vials
No applicable mixing data
The available sources describe prepared products or do not establish a reconstitution method.10
Full storage notes from Pep-Pedia
10Check specific product - some room temperature, others require refrigeration. Protect from light.
Storage depends on the formulation, diluent, container, and handling. Follow the specific product label or pharmacist’s instructions.
Research findings
No blend trialsSource context
No standardized formulation or validated universal cycle; source compatibility labels are not safety findings.
Compound identity & other names
A nonstandard lipotropic mixture, often with carnitine or vitamins. Published research on individual nutrients does not establish weight loss or safety for the named injectable blend.
Investigational or nonstandard product; no FDA-approved formulation verified for this exact entry.
How it may work
Methylation, lipid transport and nutrient-cofactor pathways; formulations may include additional drugs.10
Ingredient evidence does not test the blend
The listed bibliography concerns individual nutrients, other formulations or broad nutrition research. No controlled study of this exact named injectable combination was identified in the targeted search.
1Research areas and evidence gaps
- No validated combined-product PK, interactions or clinical response timeline.
- Research-market product identity, purity and formulation cannot be established from a publication.
Community reports Unvalidated
Wellness discussions as described by Pep-Pedia.1
No representative survey, independently verified products, or controlled outcomes.
Search coverage and review status
No additional 2025–2026 peer-reviewed efficacy trial of this exact product was identified in this targeted check. Earlier evidence and unresolved listed references are retained.
- Checked
- 2026-10-12
- Search
- "Lipo-C" lipotropic trial site:pubmed.ncbi.nlm.nih.gov
- Catalog
- Pep-Pedia ↗ · 8 listed references retained
- Targeted search, not an exhaustive systematic review.
- Bibliography-only entries are retained for traceability and are not treated as verified findings.
- Dietary protein and bone-health review does not test Lipo-C injections.
AI-prepared summaries. Independent medical editorial review is pending.
References
Original sources and review status. Open a reference to read its summary.
1Pep-Pedia: Lipo-C — community referenceCommunity source checked
AI-PREPARED SUMMARY
Accessed October 12, 2026. Secondary descriptions and bibliography; community schedules are unvalidated reports, not recommendations.
Ingredient evidence does not test the blend
The listed bibliography concerns individual nutrients, other formulations or broad nutrition research. No controlled study of this exact named injectable combination was identified in the targeted search.
2Choline Deficiency and Fatty Liver - Zeisel et al.Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: Low-choline diets produced liver-fat accumulation and injury; deficiency studies do not establish Lipo-C injection efficacy.
Reported population / model
Human
Reported study details
Low-choline diets · Variable duration · Fatty liver and liver damage
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
3Myo-Inositol for PCOS - Systematic Review (2023)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: Inositol studies showed some insulin-related changes in PCOS, while the source also acknowledges limited and inconclusive overall evidence.
Reported population / model
Meta-analysis
Reported study details
Multiple RCTs · PCOS patients · Improved insulin sensitivity
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
4L-Carnitine Weight Loss Meta-Analysis (2020)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: L-carnitine studies showed modest pooled weight and fat changes; the findings do not test the combined Lipo-C injection.
Reported population / model
37 RCTs
Reported study details
Various populations · Modest effect · -1.21 kg body weight
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
5Myo-Inositol Metabolic Effects - Meta-Analysis (2017)Pep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: Myo-inositol trials reported lower fasting insulin/HOMA and lipid changes in PCOS; this is ingredient-specific evidence.
Reported population / model
9 RCTs
Reported study details
PCOS patients · Decreased fasting insulin and HOMA index
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
6Choline and Inositol in Liver Fat - Animal StudyPep-Pedia report · Primary source not checked
AI-PREPARED SUMMARY
Pep-Pedia reports: Exercising rats receiving choline/inositol had 6.69% versus 9.22% liver fat; the study does not establish human injection outcomes.
Reported population / model
Rats
Reported study details
Aerobically trained · Reduced liver fat (6.69% vs 9.22%)
Reported by Pep-Pedia; the linked publication, design, doses and result have not been independently verified here.
Read the Pep-Pedia report ↗Pep-Pedia reference card; original summary of its reported findings · Checked 2026-10-12
7Choline: an essential nutrient for public healthLinked reference · Not independently reviewed
REFERENCE NOTE
Listed in Pep-Pedia’s bibliography; the linked publication and its findings have not been independently verified in this pass.
Pep-Pedia bibliography · Checked 2026-10-12
8Dietary protein and bone health: a systematic review and meta-analysis from the National Osteoporosis FoundationDietary protein and bone-health review does not test Lipo-C injections.Linked reference · Not independently reviewed
REFERENCE NOTE
Bibliography retained for traceability. Dietary protein and bone-health review does not test Lipo-C injections.
Pep-Pedia bibliography · Checked 2026-10-12
9Methionine metabolism in mammalsLinked reference · Not independently reviewed
REFERENCE NOTE
Listed in Pep-Pedia’s bibliography; the linked publication and its findings have not been independently verified in this pass.
Pep-Pedia bibliography · Checked 2026-10-12
10Pep-Pedia: Lipo-C — route-specific referenceReference page checked; underlying claims require separate verification.Community source checked
AI-PREPARED SUMMARY
Source page checked across available routes. Protocols, cycles, storage, mechanisms and pairing claims are secondary reports; checking the page does not independently validate those claims. Original concise summaries are used here.
Content coverage audit · Checked 2026-10-12